Samumed to start Phase II Trials

Samumed has a novel Wnt agonist, and they completed Phase I for Androgenetic Alopecia last year in Australia. If anybody is interested in joining the trial…go for it. :smiley:

http://www.clinicaltrials.gov/ct2/show/NCT02275351
http://www.clinicaltrials.gov/ct2/show/study/NCT02275351#contacts

Another company under the radar? I never heard of this one. It looks as if they have already did a phase I their phase 2 should start in Nov and conclude Nov 2015. Seems similar to histogen but still good to have another player